Back to top
more

Delcath Systems (DCTH)

(Delayed Data from NSDQ)

$5.56 USD

5.56
76,812

+0.12 (2.21%)

Updated May 3, 2024 04:00 PM ET

After-Market: $5.57 +0.01 (0.18%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for DCTH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

Delcath Systems, Inc. [DCTH]

Reports for Purchase

Showing records 121 - 140 ( 149 total )

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 121

04/05/2012

Industry Report

Pages: 5

LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of April 8

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 122

04/05/2012

Company Report

Pages: 8

2nd Generation Filter Approved in EU - Reiterate OUTPERFORM and $12 Fair Value

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 123

03/23/2012

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of March 25

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 124

03/22/2012

Industry Report

Pages: 11

Healthcare -Med Tech: Notes from the Podium - Highlights from the 2012 ROTH OC Conf

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 125

03/16/2012

Daily Note

Pages: 22

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 75.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 126

03/16/2012

Company Report

Pages: 7

Main Programs On Track; Catalysts Pick Up in Back Half of the Year; Buy

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 127

03/12/2012

Company Report

Pages: 6

Q4:11 Update

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 128

03/08/2012

Daily Note

Pages: 18

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 50.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 129

02/27/2012

Company Report

Pages: 5

Continues to Execute on EU CHEMOSTAT Launch Plans - We See Potential Upside to Pricing; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 130

11/07/2011

Company Report

Pages: 6

Q3:11 EPS a Non-Event, EU Launch of Second Generation Chemosat on Track for Q1:12

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 131

11/04/2011

Industry Report

Pages: 5

The Week Ahead in Life Sciences

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 132

10/27/2011

Daily Note

Pages: 4

Pre-NDA Meeting Scheduled for Mid- January, Key Catalysts Remain FDA and EU Launch, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 133

10/04/2011

Industry Report

Pages: 24

Biotechnology/Biopharmaceuticals/BioDefense: October 2011 Potential Milestones & Key Events - Monthly Update.

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 134

09/26/2011

Daily Note

Pages: 5

Updated Melanoma and Neuroendocrine Median OS Data - Management Changes in Preparation for Launch

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 135

09/23/2011

Industry Report

Pages: 5

LIFE SCIENCES: The Week Ahead in Life Sciences - Upcoming Events for the Week of September 25

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 136

09/01/2011

Company Report

Pages: 6

Colon Study Ineffective, but Small Number of Patients, Remain OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 137

09/01/2011

Industry Report

Pages: 22

Biotechnology/Biopharmaceuticals/BioDefense: September 2011 Potential Milestones & Key Events - Monthly Update.

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 75.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 138

08/04/2011

Company Report

Pages: 6

Q2 Results - Non-Event, Next Up Safety Data in September and NDA Resubmission

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 25.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 139

04/13/2011

Daily Note

Pages: 4

CE Mark Approved, EU Product Launch Expected in 2012

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party

Company: Delcath Systems, Inc.

Industry: Medical - Instruments

Record: 140

04/11/2011

Daily Note

Pages: 4

QUICK NOTE

Provider: WEDBUSH SECURITIES INC.

Analyst: WADE G

Price: 10.00

Research Provided by a Third Party